Davide Quaresmini

Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma

Michele Guida, Nicola Bartolomeo, Davide Quaresmini et al. · Journal of Translational Medicine · 2022 · 65 citations · Full text

DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors

Mauro Cives, Stefano Partelli, Raffaele Palmirotta et al. · Scientific Reports · 2019 · 44 citations · Full text

Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA)

Raffaele Palmirotta, Domenica Lovero, Erica Silvestris et al. · Cancer Genomics & Proteomics · 2017 · 41 citations · Full text

Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From Italy

Sabino Strippoli, Annarita Fanizzi, Davide Quaresmini et al. · Frontiers in Oncology · 2021 · 40 citations · Full text

No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study

Michele Guida, Nicola Bartolomeo, Pietro Quaglino et al. · Cancers · 2021 · 29 citations · Full text